About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Therapeutic Target for Ewing Sarcoma Identified

by Anjali Aryamvally on April 7, 2018 at 1:31 PM
Font : A-A+

New Therapeutic Target for Ewing Sarcoma Identified

A potential new therapeutic target for Ewing sarcoma has been identified by the sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado.

Ewing sarcoma is the second most frequent bone cancer in children and adolescents, and a tumor known by its aggressiveness and tendency to metastasize. The research, published in International Journal of Cancer, has been funded almost entirely by the Alba Pérez Foundation, a non-profit organization dedicated to this disease.

Advertisement


For years, the main line of research of the Ewing sarcoma group focused on the caveolin 1 protein (CAV1), which has been associated to treatment resistance and metastasis, among other issues. However, the location of this protein in the cell makes its use as a therapeutic target virtually impossible. "That is why we were looking for a CAV1 cofactor with an equally relevant role but a more accessible location", explains Dr. Martínez-Tirado, "and the EphA2 membrane receptor, already described in previous studies, meets these requirements."

In their latest work, researchers not only demonstrate the connection between the EphA2 receptor and caveolin 1, but also establish a correlation between the phosphorylation of EphA2 and the aggressiveness of tumors in Ewing sarcoma. "In several in vitro and in vivo tests, we observed that this membrane receptor plays a key role in the migration of tumor cells."
Advertisement

Regarding in vivo studies, the research team used two different models. The artificial model of metastasis, more experimental, allows researchers to assess the ability of cells to adhere to the pulmonary epithelium in adverse conditions. On the other hand, the new orthotopic model developed by the same group a few months ago induces a spontaneous metastasis, much more similar to what can be observed in a clinical setting.

"In the lab, we have shown that the lack of EphA2 receptor significantly decreases the incidence and number of metastases", says Dr. Martínez-Tirado, "and thanks to our collaboration with Hospital Virgen del Rocío, we also saw that 90% of Ewing sarcoma patients express this receptor (mimicking caveolin 1), a fundamental fact when it comes to selecting EphA2 as a therapeutic target. At the same time, working with patient samples also allowed us to correlate EphA2 ligand-independent activity, associated with its phosphorylation, with lower survival. "

Thanks to the stable financial support of the Alba Pérez Foundation, IDIBELL researchers will keep on working on the development of treatments based on blocking the activity of this receptor. "Through drug nanoengineering techniques, we aim to develop a molecule with a double effect, capable of blocking EphA2 in tumor cells and delivering other targeted drugs at the same time", concludes the IDIBELL researcher.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Rhabdomyosarcoma Ewing Sarcoma Liposarcoma Fallopian Tube Cancer 

Recommended Reading
Two Mutations Linked to Ewing Sarcoma Subtype With Poor Prognosis
Frequent mutations in two genes that often occur together in Ewing sarcoma (EWS) have been ......
Ewing Sarcoma Tumor Growth Accelerated by Single Genetic Abnormality
Bone cancer Ewing sarcoma is driven by a genetic abnormality that operates through two distinct ......
New Drug Discovered for Treatment of Ewing Sarcoma
"Ewing sarcoma is almost always caused by a cancer-causing protein called EWS/FLI," said Stephen ......
Experimental Breast Cancer Drug Could Work for Ewing Sarcoma
A combination therapy that included drugs from a family of experimental agents developed to fight .....
Ewing Sarcoma
Ewing sarcoma is a primary tumor of small round cells that affects bones and soft tissues. It affect...
Fallopian Tube Cancer
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are pair...
Liposarcoma
Liposarcoma is a cancer of the fat cells in the body. It can occur anywhere in the body but most com...
Rhabdomyosarcoma
Rhabdomyosarcoma is a rare type of cancer affecting the striated muscles. It mostly occurs in ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
X